Literature DB >> 2999618

Evidence for an A2 adenosine receptor in guinea pig lung.

D Ukena, C G Schirren, K N Klotz, U Schwabe.   

Abstract

Adenosine receptors in guinea pig lung were characterized by measurement of cyclic AMP formation and radioligand binding. 5'-N-Ethylcarboxamidoadenosine (NECA) increased cyclic AMP levels in lung slices about 4-fold over basal values with an EC50 of 0.32 mumol/l. N6-R-(-)-Phenylisopropyladenosine (R-PIA) was 5-fold less potent than NECA. 5'-N-Methylcarboxamidoadenosine (MECA) and 2-chloroadenosine had EC50-values of 0.29 and 2.6 mumol/l, whereas adenosine and inosine had no effect. The adenosine receptors in guinea pig lung can therefore be classified as A2 receptors. Several xanthine derivatives antagonized the NECA-induced increase in cyclic AMP levels. 1,3-Diethyl-8-phenylxanthine (DPX; Ki 0.14 mumol/l) was the most potent analogue, followed by 8-phenyltheophylline (Ki 0.55 mumol/l), 3-isobutyl-1-methylxanthine (IBMX; Ki 2.9 mumol/l) and theophylline (Ki 8.1 mumol/l). In contrast, enprofylline (1 mmol/l) enhanced basal and NECA-stimulated cyclic AMP formation. In addition, we attempted to characterize these receptors in binding studies with [3H] NECA. The KD for [3H]NECA was 0.25 mumol/l and the maximal number of binding sites was 12 pmol/mg protein. In competition experiments MECA (Ki 0.14 mumol/l) was the most potent inhibitor of [3H]NECA binding, followed by NECA (Ki 0.19 mumol/l) and 2-chloroadenosine (Ki 1.4 mumol/l). These results correlate well with the EC50-values for cyclic AMP formation in lung slices. However, the Ki-values of R-PIA and theophylline were 240 and 270 mumol/l, and DPX and 8-phenyltheophylline did not compete for [3H] NECA binding sites. Therefore, a complete characterization of A2 adenosine receptors by [3H]NECA binding was not achieved.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2999618     DOI: 10.1007/bf00498856

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  33 in total

1.  Potentiation of mast cell mediator release by adenosine.

Authors:  D L Marquardt; C W Parker; T J Sullivan
Journal:  J Immunol       Date:  1978-03       Impact factor: 5.422

2.  Characterization of the adenosine receptor responsible for the inhibition of histamine and SRS-A release from human lung fragments.

Authors:  P A Hillyard; A T Nials; I F Skidmore; C J Vardey
Journal:  Br J Pharmacol       Date:  1984-10       Impact factor: 8.739

3.  Adenosine antagonism by purines, pteridines and benzopteridines in human fibroblasts.

Authors:  R F Bruns
Journal:  Biochem Pharmacol       Date:  1981-02-15       Impact factor: 5.858

4.  Functional identification of adenylate cyclase-coupled adenosine receptors in rat brain microvessels.

Authors:  W Schütz; G Steurer; E Tuisl
Journal:  Eur J Pharmacol       Date:  1982-11-19       Impact factor: 4.432

5.  Dependence of ionophore- and caffeine-induced calcium release from sarcoplasmic reticulum vesicles on external and internal calcium ion concentrations.

Authors:  A M Katz; D I Repke; W Hasselbach
Journal:  J Biol Chem       Date:  1977-03-25       Impact factor: 5.157

6.  Specific binding of 3H-adenosine to rat brain membranes.

Authors:  U Schwabe; H Kiffe; C Puchstein; T Trost
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-12       Impact factor: 3.000

7.  Release of adenosine from rat lung by antigen and compound 48/80.

Authors:  B B Fredholm
Journal:  Acta Physiol Scand       Date:  1981-04

8.  Xanthine derivatives as adenosine receptor antagonists.

Authors:  B B Fredholm; C G Persson
Journal:  Eur J Pharmacol       Date:  1982-07-30       Impact factor: 4.432

9.  Effects of beta-adrenergic receptor blockade on airway conductance and lung volume in normal and asthmatic subjects.

Authors:  P S Richardson; G M Sterling
Journal:  Br Med J       Date:  1969-07-19

10.  Xanthine derivatives as antagonists at A1 and A2 adenosine receptors.

Authors:  U Schwabe; D Ukena; M J Lohse
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-09       Impact factor: 3.000

View more
  6 in total

1.  Behavioral effects of adenosine analogs in squirrel monkeys: relation to adenosine A2 receptors.

Authors:  R D Spealman; V L Coffin
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

2.  A [3H]amine congener of 1,3-dipropyl-8-phenylxanthine. A new radioligand for A2 adenosine receptors of human platelets.

Authors:  D Ukena; K A Jacobson; K L Kirk; J W Daly
Journal:  FEBS Lett       Date:  1986-04-21       Impact factor: 4.124

3.  [3H]xanthine amine congener of 1,3-dipropyl-8-phenylxanthine: an antagonist radioligand for adenosine receptors.

Authors:  K A Jacobson; D Ukena; K L Kirk; J W Daly
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

4.  The regulation of lung liquid absorption by endogenous cAMP in postnatal sheep lungs perfused in situ.

Authors:  R H Stephens; A R Benjamin; D V Walters
Journal:  J Physiol       Date:  1998-09-01       Impact factor: 5.182

5.  Glomeruli and microvessels of the rabbit kidney contain both A1- and A2-adenosine receptors.

Authors:  M Freissmuth; V Hausleithner; E Tuisl; C Nanoff; W Schütz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-04       Impact factor: 3.000

6.  2-Chloroadenosine induction of vagally-mediated and atropine-resistant bronchomotor responses in anaesthetized guinea-pigs.

Authors:  S Manzini; L Ballati
Journal:  Br J Pharmacol       Date:  1990-06       Impact factor: 8.739

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.